Puzzle Medical Devices Inc. announces the closing of its major Seed financing round to support its first-in-human study
MONTREAL, January 24, 2022 /PRNewswire/ – Montreal based Puzzle Medical Devices Inc., a medical device...
Search for Articles
Jan 24, 2022
Dec 9, 2021
Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere’s Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema
NEW HAVEN, Conn. and NANJING, China, Dec. 9, 2021 /PRNewswire/ -- Simcere Pharmaceutical Group and Aeromics,...
Nov 15, 2021
Renovacor Announces Third Quarter 2021 Financial Results and Provides Corporate Update
PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...
Oct 4, 2021
Renovacor Announces the Appointment of Kumar Dhanasekharan, Ph.D., as Senior Vice President of Technical Operations
PHILADELPHIA--(BUSINESS WIRE)--Renovacor, Inc. (NYSE: RCOR), a biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for...
Sep 22, 2021
Renovacor Announces the Appointment of Jordan Shin, M.D., Ph.D., as Senior Vice President of Clinical Development and Translational Science
Dr. Shin to help advance REN-001 into the clinic by leveraging nearly two decades of...
Sep 2, 2021
Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
PHILADELPHIA--(BUSINESS WIRE)--Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for...